Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo

Journal of Biomedical Nanotechnology

Volumn 7, Issue 6, 2011, Pages 768-775

  Wei, Wei ^a   Mu, Yandong ^b   Li, XiaoPeng ^c   Gou, MaLing ^a   Zhang, HaiLong ^a   Luo, ShunTao ^a   Men, Ke ^a   Mao, YongQiu ^a   Qian, ZhiYong ^a   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c SuZhou Genemen Biotech Co Ltd   (China)

Author keywords

Adenovirus; Endostatin; Heparin; Polyethyleneimine; Pulmonary metastasis; Target

Indexed keywords

ADENOVIRUS; ENDOSTATINS; HEPARIN; POLYETHYLENEIMINE; PULMONARY METASTASIS;

BIOLOGICAL ORGANS; CELLS; CYTOLOGY; FUNCTIONAL POLYMERS; GENES; MANGANESE; MOLECULAR WEIGHT; NANOSTRUCTURED MATERIALS; ORGANIC POLYMERS; PATHOLOGY; POLYETHYLENES; POLYSACCHARIDES; TARGETS; TUMORS; VECTORS;

MOLECULAR BIOLOGY;

ADENOVIRUS VECTOR; HEPARIN; LUCIFERASE; NANOMATERIAL; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GEL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; LUNG PARENCHYMA; MOUSE; NONHUMAN;

ADENOVIRIDAE; ANIMALS; CELL PROLIFERATION; DRUG CARRIERS; FEMALE; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HEPARIN; HISTOCYTOCHEMISTRY; HUMANS; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863030708     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1349     Document Type: Article

References (33)

1. R. Alemany, C. Gomez-Manzano, C. Balague, W. K. Yung, D. T. Curiel, A. P. Kyritsis, and J. Fueyo, Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp. Cell. Res. 252, 1 (1999).
2. G. J. Bauerschmitz, S. D. Barker, A. Hemminki, Adenoviral gene therapy for cancer: From vectors to targeted and replication competent agents (review). Int. J. Oncol. 21, 1161 (2002).
3. N. Morral, W. K. O'Neal, K. Rice, M. M. Leland, P. A. Piedra, E. Aquilar-Cordova, K. D. Carey, A. L. Beaudet, and C Langston, Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene. Ther. 13, 143 (2002).
4. R. Singh, B. Tian, and K. Kostarelos, Artificial envelopment of nonenveloped viruses: Enhancing adenovirus tumor targeting in-vivo. FASEB. J. 22, 3389 (2008).
5. A. A. Rivera, J. Davydova, S. Schierer, M. Wang, V. Krasnykh, M. Yamamoto, D. T. Curiel, D. M. Nettelbeck, Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells. Gene. Ther. 11, 1694 (2004).
6. A. Kanerva and A. Hemminki, Modified adenoviruses for cancer gene therapy. Int J Cancer. 110, 475 (2004).
7. J. T. Douglas, B. E. Rogers, M. E. Rosenfeld, Sl. Michael, M. Feng, D. T. Curiel, Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14, 1574 (1996).
8. K. D. Fisher, Y. Stallwood, N. K. Green, K. Ulbrich, V. Mautner, L. W. Seymour, Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene. Ther. 8, 341 (2001).
9. U. Lungwitz, M. Breuning, T. Blunk, and A. Gopferich, Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60, 247 (2005).
10. M. Neu, D. Fischer, and T. Kissel, Recent advances in rational gene transfer vector design based on Polyethylenimine and its derivatives. J. Gene. Med. 7, 992 (2005).
11. N. Csaba, M. Köping-Höggård, E. Fernandez-Megia, R. Novoa- Carballal, R. Riguera, and M. J. Alonso, Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 5, 162 (2009).
12. R. Goyal, S. K. Tripathi, S. Tyagi, K. Ravi Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. Kar Chowdhuri, and K. C. Gupta, Gellan Gum-PEI nanocomposites as efficient gene delivery agents. J. Biomed. Nanotechnol. 7, 38 (2011).
13. T. Liu, X. Yu, B. Kan, Q. Guo, X. Wang, S. Shi, G. Guo, F. Luo, X. Zhao, Y. Wei, and Z. Qian, Enhanced gene delivery using biodegradable poly(ester amine)s (PEAs) based on low-molecular-weight polyethylenimine and poly(-caprolactone)- pluronic-poly(-caprolactone). J. Biomed. Nanotechnol. 6, 351 (2010).
14. H.-L. Jiang, M. Nagaoka, Y.-K. Kim, R. Arote, D. Jere, I.-Y. Park, T. Akaike, and C.-S. Cho, Gene delivery to stem cells by combination of chitosan-graft-polyethylenimine as a gene carrier and E-Cadherin-IgG Fc as an extracellular matrix. J. Biomed. Nanotechnol. 3, 377 (2007).
15. F. Verbaan, I. van Dam, Y. Takakura, M. Hashida, W. Hennink, G. Storm, and C. Qussoren, Intravenous fate of poly(2- (dimethylamino)ethyl methacrylate)-based polyplexes. Eur. J. Pharm. Sci. 20, 419 (2003).
16. D. B. Fenske, I. MacLachlan, P. R. Cullis, Long-circulating vectors for the systemic delivery of genes. Curr. Opin. Mol. Ther. 3, 153 (2001).
17. M. Ogris and E. Wagner, Targeting tumors with non-viral gene delivery systems. Drug. Discov. Today. 7, 479 (2002).
18. C. Passirani, G. Barratt, J. P. Devissaguet, and D. Labarre, Long-circulating nanparticles bearing heparin or dextran covalently bound to poly (methylmethacrylate). Pharm. Res. 15, 1046 (1998).
19. O. Jeon, H. S. Yang, T. J. Lee, and B. S. Kim, Heparin-conjugated polyethylenimine for gene delivery. J. Control. Release. 132, 236 (2008).
20. D. A. Norris, N. Puri, and P. J. Sinko, The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug. Deliv. Rev. 34, 135 (1998).
21. L. Yang, L. Wang, X. Q. Su, L. Wang, X. C. Chen, D. Li, S. T. Luo, H. S. Shi, L. J. Chen, and Y. S. Wang, Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin. Cancer. Gene. Ther. 17, 49 (2010).
22. T. C. He, S. B. Zhou, D. A. Costa, L. T. Yu, J. Kinzler, and K. W. Vogelstein, A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95, 2509 (1998).
23. M. Gou, K. Men, J. Zhang, Y. H. Li, J. Song, S. Luo, H. S. Shi, Y. J. Wen, G. Guo, M. J. Huang, X. Zhao, Z. Y. Qian, and Y. Q. Wei, Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethylenimine. ACS. Nano 4, 5573 (2010).
24. X. C. Peng, L. Yang, L. P. Yang, Y. Q. Mao, H. S. Yang, J. Y. Liu, D. M. Zhang, L. J. Chen, and Y. Q. Wei, Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34->Ala mutant. J. Exp. Clin. Cancer. Res. 27, 46 (2008).
25. M. Lee, J. Rentz, S. O. Han, D. A. Bull, and S. W. Kim, Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene. Ther. 10, 585 (2003).
26. W. T. Godbey, K. K. Wu, and A. G. Mikos, Size matters: Molecular weight affects the efficiency of poly (ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. 45, 268 (1999).
27. F. Alexis, S. L. Lo, and S. Wang, Covalent attachment of low molecular weight poly (ethylene imine) improvement tat peptide mediated gene delivery. Adv. Mater. 18, 2174 (2006).
28. Y. Wen, S. Pan, X. Luo, X. Zhang, and M. Feng, A biodegradable low molecular weight Polyethylenimine derivative as low toxicity and efficient gene vector. Bioconjugate. Chem. 20, 322 (2009).
29. E. M. Lee, S. H. Hong, Y. J. Lee, K. C. Choi, S. H. Choi, I. H. Kim, and S. J. Lim, Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor. J. Cancer. Res. Clin. Oncol. 130, 169 (2004).
30. D. C. Litzinger, J. M. Brown, I. Wala, S. A. Kaufman, G. F. Van, C. L. Farrell, and D. Collins, Fate of cationic liposomes and their complex with oligonucleotide in-vivo. Biochim. Biophys. Acta. 128, 139 (1996).
31. M. Yamashita, A. Ino, K. Kawabata, F. Sakurai, and H. Mizuquchi, Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells. Int. J. Cancer. 121, 1690 (2007).
32. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27 (1995).
33. M. S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. S. Lane, E. Flynn, J. R. Birkhead, B. R. Olsen, and J. Folkman, Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88, 277 (1997).